Contents
Current Pharmaceutical Biotechnology, Volume 13 - Number 10
Editorial
Editorial: [Hot Topic: Drug Development in Dermatology: New Targets for Old Diseases?]
, 13(10): 1859 - 1860Riccardo G. Borroni
DOI: 10.2174/138920112802273317
Psoriasis, from Pathogenesis to Therapeutic Strategies: IL-21 as a Novel Potential Therapeutic Target
, 13(10): 1861 - 1867Elisabetta Botti, Giulia Spallone, Roberta Caruso, Giovanni Monteleone, Sergio Chimenti and Antonio Costanzo
DOI: 10.2174/138920112802273281
Gene Therapy of Skin Adhesion Disorders (Mini Review)
, 13(10): 1868 - 1876Alessia Cavazza and Fulvio Mavilio
DOI: 10.2174/138920112802273119
Apoptotic Pathways in the Pathogenesis of Pemphigus: Targets for New Therapies
, 13(10): 1877 - 1881Roberta Lotti, Alessandra Marconi and Carlo Pincelli
DOI: 10.2174/138920112802273236
Role of Defensins and Cathelicidin LL37 in Auto-Immune and Auto- Inflammatory Diseases
, 13(10): 1882 - 1897Loredana Frasca and Roberto Lande
DOI: 10.2174/138920112802273155
New Pharmaceutical Concepts for Sebaceous Gland Diseases: Implementing Today’s Pre-Clinical Data into Tomorrow’s Daily Clinical Practice
, 13(10): 1898 - 1913Vasiliki A. Zampeli, Evgenia Makrantonaki, Thrasivoulos Tzellos and Christos C. Zouboulis
DOI: 10.2174/138920112802273173
Editorial
Editorial: [Hot Topic: Antidotes and Rescue Therapies]
, 13(10): 1914 - 1916Richard Y. Wang and Ziad N. Kazzi
DOI: 10.2174/138920112802273164
Acetylcysteine Therapy for Acetaminophen Poisoning
, 13(10): 1917 - 1923Kennon Heard and Jody Green
DOI: 10.2174/138920112802273146
Antidote Control of Aptamer Therapeutics: The Road to a Safer Class of Drug Agents
, 13(10): 1924 - 1934K. M. Bompiani, R. S. Woodruff, R. C. Becker, S. M. Nimjee and B. A. Sullenger
DOI: 10.2174/138920112802273137
Antidotes for Acute Cyanide Poisoning
, 13(10): 1940 - 1948Stephen W. Borron and Frederic J. Baud
DOI: 10.2174/138920112802273182
Calcium and Zinc DTPA Administration for Internal Contamination with Plutonium-238 and Americium-241
, 13(10): 1957 - 1963Ziad N. Kazzi, Alexander Heyl and Johann Ruprecht
DOI: 10.2174/138920112802273308
Legalon® SIL: The Antidote of Choice in Patients with Acute Hepatotoxicity from Amatoxin Poisoning
, 13(10): 1964 - 1970Ulrich Mengs, Ralf - Torsten Pohl and Todd Mitchell
DOI: 10.2174/138920112802273353
Reactive Skin Decontamination Lotion (RSDL) for the Decontamination of Chemical Warfare Agent (CWA) Dermal Exposure
, 13(10): 1971 - 1979M. D. Schwartz, C. G. Hurst, M. A. Kirk, S. J.D. Reedy and E. H. Braue
DOI: 10.2174/138920112802273191
Antivenoms for Snakebite: Design, Function, and Controversies
, 13(10): 1980 - 1986Eric J. Lavonas
DOI: 10.2174/138920112802273227
Editorial
Ectopic Lymphoid Neogenesis and Lymphoid Chemokines in Sjogren’s Syndrome: At the Interplay between Chronic Inflammation, Autoimmunity and Lymphomagenesis
, 13(10): 1989 - 1996Michele Bombardieri and Costantino Pitzalis
DOI: 10.2174/138920112802273209
Biologic Therapies in Primary Sjögren's Syndrome
, 13(10): 1997 - 2008S. J. Bowman
DOI: 10.2174/138920112802273263
Local Activation and Systemic Dysregulation of T Lymphocytes in Sjögren’s Syndrome
, 13(10): 2009 - 2021Robert Busch, Andreas V. Hadjinicolaou and Frances C. Hall
DOI: 10.2174/138920112802273092
Primary Sjogren’s Syndrome: Time for Prospective Cohorts
, 13(10): 2022 - 2025Jacques-Eric Gottenberg and Xavier Mariette
DOI: 10.2174/138920112802273128
Current and Future Challenges in Primary Sjogren’s Syndrome
, 13(10): 2026 - 2045Arjan Vissink, Hendrika Bootsma, Fred KL Spijkervet, Shen Hu, David T Wong and Cees GM Kallenberg
DOI: 10.2174/138920112802273254
Epigenetics and Sjogren’s Syndrome
, 13(10): 2046 - 2053Christelle Le Dantec, Marie-Michele Varin, Wesley H Brooks, Jacques-Olivier Pers, Pierre Youinou and Yves Renaudineau
DOI: 10.2174/138920112802273326
Primary Sjogren’s Syndrome and the Type I Interferon System
, 13(10): 2054 - 2062Gunnel Nordmark, Maija-Leena Eloranta and Lars Ronnblom
DOI: 10.2174/138920112802273290
Autoantibodies and Sjogren’s Syndrome: A Physiologist’s Perspective
, 13(10): 2063 - 2070Peter M. Smith and Luke J. Dawson
DOI: 10.2174/138920112802273218
B-Lymphocytes Govern the Pathogenesis of Sjogren's Syndrome
, 13(10): 2071 - 2077Pierre Youinou, Alain Saraux and Jacques-Olivier Pers
DOI: 10.2174/138920112802273100
Principles and Applications of Selective Biophysical Methods for Characterization and Comparability Assessment of a Monoclonal Antibody
, 13(10): 2078 - 2101Haripada Maity, Yin Lai, Arvind Srivastava and Joel Goldstein
DOI: 10.2174/138920112802273344
Webmaster Contact: info@benthamscience.org